See every side of every news story

Published 6 hours ago • loading... • Updated 5 hours ago

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

Summary by Benzinga

BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer. Mr. Ramanayake brings over 20 years of global biopharmaceutical leadership experience, with a strong track record in business development, strategic transactions, and advancing innovative ther…

4 Articles

4 Articles

+3 Reposted by 3 other sources

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer. Mr. Ramanayake brings over 20 years of global biopharmaceutical leadership experience, with a strong track record in business development, strategic transactions, and advancing innovative ther…

6 hours ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources4

Leaning Left0Leaning Right0Center1Last Updated2 hours agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

dailyguardian.ca broke the news in 10 hours ago on Monday, March 23, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics